Who is sponsoring NCT04859192?

NCT04859192 is sponsored by Mansoura University.

What drugs are being tested in NCT04859192?

Interventions in NCT04859192: gamified flipped classroom.

What condition does NCT04859192 study?

NCT04859192 studies Gamified Flipped Classroom, Education, Nursing Students.

Is NCT04859192 still recruiting?

NCT04859192 is currently completed. Last updated 11 April 2022.

Last reviewed 2022-04-11 · How we verify

NCT04859192

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gamified Flipped Class Room and Nursing Students' Skills Competency and Confidence

Completed NA Last updated 11 April 2022

What this trial tests

NA trial testing gamified flipped classroom in Gamified Flipped Classroom in 128 participants. Completed in 15 February 2022.

Timeline

22 April 2021

Primary endpoint
20 July 2021

15 February 2022

Quick facts

Lead sponsor	Mansoura University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	128
Start date	22 April 2021
Primary completion	20 July 2021
Estimated completion	15 February 2022
Sites	1 location across Egypt

Drugs / interventions tested

gamified flipped classroom

Conditions studied

Gamified Flipped Classroom — all drugs for Gamified Flipped Classroom →
Education, Nursing Students — all drugs for Education, Nursing Students →

Sponsor

Mansoura University

Who can join

18 and older, any sex, with Gamified Flipped Classroom or Education, Nursing Students. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

one of the primary components of effective teaching is student engagement and that engagement is critical for learning

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of gamified flipped classroom on improving nursing students' skills competency and learning motivation: a randomized controlled trial.
Elzeky MEH, Elhabashy HMM, Ali WGM, Allam SME. · · 2022 · cited 19× · PMID 36384544 · DOI 10.1186/s12912-022-01096-6

Verify or expand the search:

Other Mansoura University trials

Trials by the same sponsor.

NCT05785377 — Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
NCT07509567 — Conventional Palatal Crib Versus Bonded Spurs for Anterior Open Bite Treatment · NA · not yet recruiting
NCT07393178 — Efficacy & Safety of High Power vs. Low Power Holmium Laser in Mini-PCNL for Large Renal Stones · NA · not yet recruiting
NCT07436182 — Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. · Phase 4 · not yet recruiting
NCT07534943 — Effectiveness of Oleanolic Acid as Intracanal Medicament on Infectious/Inflammatory Contents in Teeth With Apical Period · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04859192 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mansoura University
Last refreshed: 11 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04859192.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing